Teva Pharmaceutical on Tuesday announced the U.S. Supreme Court’s decision in Teva Pharmaceuticals USA vs. Sandoz et al. that reversed the Federal Circuit Court’s judgment of invalidity of Teva’s ‘808 patent for Copaxone (glatiramer acetate injection) 20 mg/mL.
The Food and Drug Administration has expanded the age indication for Natroba (spinosad) topical suspension 0.9% to include children 6 months of age and older who have head lice infestations (pediculosis capitis).
The Pharmacy Quality Alliance and The American Journal of Pharmacy Benefits on Tuesday announced a partnership in which PQA will contribute a new column to each AJPB issue entitled, "Medication Quality Matters."
Lay's brand announced the return of its popular "Do Us A Flavor" contest. Beginning today, fans can submit their ideas for the next potato chip flavor for a chance at nabbing a $1 million prize. But with the return of the contest comes a twist.